Psychological impact over time of women with pregnancy loss due to gestational trophoblastic disease compared with miscarriage

被引:0
|
作者
Blok, Laura [1 ,2 ,6 ]
Eysbouts, Yalcke [3 ]
Lok, Christianne A. R. [4 ]
Coppus, S. F. P. J. [5 ]
Sweep, Fred C. G. J. [1 ]
Ottevanger, Petronella [2 ]
机构
[1] Radboudumc, Dept Lab Med, Nijmegen, Netherlands
[2] Radboudumc, Dept Med Oncol, Nijmegen, Netherlands
[3] Radboudumc, Dept Obstet & Gynaecol, Nijmegen, Netherlands
[4] Netherlands Canc Inst, Dept Gynaecol Oncol, Amsterdam, Netherlands
[5] Maxima Med Ctr, Dept Obstet & Gynaecol, Veldhoven, Netherlands
[6] Radboudumc, Dept Lab Med, NL-6498 HB Nijmegen, Netherlands
关键词
gestational trophoblastic disease; QUALITY-OF-LIFE; DEPRESSION SCALE HADS; HOSPITAL ANXIETY; DUTCH VERSION; VALIDATION; HEALTH; PREDICTORS; DIAGNOSIS;
D O I
10.1136/ijgc-2023-004639
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives Pregnancy loss, occurring after miscarriage or after gestational trophoblastic disease, has a psychological impact. Besides pregnancy loss, women diagnosed with gestational trophoblastic disease have to deal with a prolonged period of follow-up and potential advice to postpone a future pregnancy. We studied the severity and course of the psychological impact after gestational trophoblastic disease and miscarriage, to identify whether women with gestational trophoblastic disease need different psychological care. Methods A prospective multicenter study using online questionnaires was performed. Women diagnosed with gestational trophoblastic disease or miscarriage received the following questionnaires directly after diagnosis, and after 6, 6, and 12 months: a self-report questionnaire, the Hospital Anxiety and Depression Scale (HADS), the Impact of Event Scale, and the Reproductive Concerns Scale. Results 74 women with gestational trophoblastic disease and 76 women with miscarriage were included. At baseline, the proportion of women scoring above the cut-off level for the anxiety subscale of the HADS and for the Impact of Event Scale was significantly higher for women with gestational trophoblastic disease than for women after miscarriage (43.2% vs 28.9%, p=0.02 and 87.8% vs 78.9%, p=0.03, respectively). During follow-up, the differences between both groups vanished and only the Impact of Event Scale after 12 months remained significantly different between women with gestational trophoblastic disease and women after miscarriage (62.7% vs 37.3%, p=0.005). All outcomes, except the Reproductive Concerns Scale, showed a significant decline. However, in women who scored above the cut-off level on the HADS-total or Impact of Event Scale at baseline, and women with psychological or psychiatric history, significant higher scores persisted. Conclusion Although women with gestational trophoblastic disease at baseline had more anxiety and distress than women after miscarriage, no significant differences were seen using the HADS-total after 12 months. Using the HADS or Impact of Event Scale directly after pregnancy loss is helpful to identify women at risk of remaining psychological symptoms to provide them with extra psychological support.
引用
收藏
页码:1882 / 1889
页数:8
相关论文
共 21 条
  • [1] Gestational age of pregnancy loss in women with unexplained recurrent miscarriage
    Ticconi, Carlo
    Giuliani, Emma
    Sorge, Roberto
    Patrizi, Lodovico
    Piccione, Emilio
    Pietropolli, Adalgisa
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2016, 42 (03) : 239 - 245
  • [2] Symptoms of anxiety and depression in women with gestational trophoblastic disease compared to women who had a miscarriage: a cross-sectional study
    Tenorio, Paula Jaeger
    Katz, Leila
    Amorim, Melania Maria Ramos
    [J]. JOURNAL OF PSYCHOSOMATIC OBSTETRICS & GYNECOLOGY, 2023, 44 (01)
  • [3] GESTATIONAL TROPHOBLASTIC DISEASE IN WOMEN OVER 50 YEARS
    NARAYANSINGH, G
    KISSOON, W
    RAMSEWAK, S
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1994, 44 (02) : 168 - 168
  • [4] The psychological impact of gestational trophoblastic disease: a prospective observational multicentre cohort study
    Blok, L. J.
    Frijstein, M. M.
    Eysbouts, Y. K.
    Custers, J. A. E.
    Sweep, F. C. G. J.
    Lok, C. A. R.
    Ottevanger, P. B.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 129 (03) : 444 - 449
  • [5] Re: The psychological impact of gestational trophoblastic disease: a prospective observational multicentre cohort study
    Sarkar, Avir
    Sharma, Arushi
    Saha, Pradip Kumar
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 129 (05) : 831 - 832
  • [6] Long-Term Psychological Morbidity, Sexual Functioning, and Relationship Outcomes in Women With Gestational Trophoblastic Disease
    Stafford, Lesley
    McNally, Orla M.
    Gibson, Penelope
    Judd, Fiona
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (07) : 1256 - 1263
  • [7] Gestational surrogacy for women with recurrent pregnancy loss due to refractory chronic histiocytic intervillositis
    Cornish, E. F.
    Belardo, C. A. A.
    Turnell, R.
    McDonnell, T.
    Williams, D. J.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2023, 130 (12) : 1552 - 1554
  • [8] Authors' response re: The psychological impact of gestational trophoblastic disease: a prospective observational multicentre cohort study
    Blok, Laura J.
    Frijstein, Minke M.
    Eysbouts, Yalck K.
    Custers, Jose A. E.
    Sweep, Fred C. G. J.
    Lok, Christianne A. R.
    Ottevanger, Petronella B.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 129 (05) : 833 - 834
  • [9] False diagnosis of and needless therapy for presumed gestational trophoblastic disease in women with an unusual site of residual pregnancy
    Gao, Tong
    Sun, Mingming
    Yao, Liangqing
    Jiang, Wei
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (02) : 673 - 681
  • [10] FALSE DIAGNOSIS OF AND NEEDLESS THERAPY FOR PRESUMED GESTATIONAL TROPHOBLASTIC DISEASE IN WOMEN WITH UNUSUAL SITE RESIDUAL PREGNANCY
    Gao, T.
    Sun, M.
    Lu, X.
    Yao, L.
    Jiang, W.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 890 - 890